John B. Landis - Feb 9, 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Feb 9, 2022
Transactions value $
$0
Form type
4
Date filed
2/11/2022, 03:54 PM
Previous filing
Jun 23, 2021
Next filing
Feb 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +2.5K +42.37% $0.00 8.4K Feb 9, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Options Exercise $0 -2.5K -100% $0.00* 0 Feb 9, 2022 Common Stock 2.5K $0.00 Direct F1
transaction EYPT Restricted Stock Units Award $0 +3K $0.00 3K Feb 9, 2022 Common Stock 3K $0.00 Direct F2
transaction EYPT Stock Option (Right to Buy) Award $0 +11K $0.00 11K Feb 9, 2022 Common Stock 11K $10.13 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested on the one-year anniversary of the grant date.
F2 Will fully vest on the one-year anniversary of the grant date.